REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Eirpharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Miscellaneous Crop Farming | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Electronic Shopping and Mail-Order Houses | Other Information Services | Internet Publishing and Broadcasting and Web Search Portals | Computer Systems Design and Related Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Management of Companies and Enterprises
Full name: Eirpharma Sp. z o.o. Profile Updated: January 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Eirpharma Sp. z o.o. is based in Poland, with the head office in Poznan. It operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on January 03, 2020. A growth of 514.21% was recorded in its total assets.

Headquarters
Ul. Mlynska 12/215
Poznan; Wielkopolskie; Postal Code: 61-730

Contact Details: Purchase the Eirpharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Eirpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Eirpharma Sp. z o.o. report to view the information.
Incorporation Date:
January 03, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Eirpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
82.73%▲
Operating profit (EBIT)
-4754.8%▼
Net Profit (Loss) for the Period
-4754.8%▼
Total assets
514.21%▲
Total equity
-3376.68%▼
Return on Equity (ROE)
27.57%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo